Gan & Lee Pharmaceuticals.
603087
Classifica tra le azioni
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Prezzo delle azioni
$10.03
Capitalizzazione di mercato
$5.99B
Variazione (1 giorno)
-3.71%
Variazione (1 anno)
2.30%
Paese
CN
Scambia Gan & Lee Pharmaceuticals. (603087)
Categoria
Healthcare
Storico del rendimento da dividendi per Gan & Lee Pharmaceuticals. (603087)
Il rendimento da dividendi (TTM) di Gan & Lee Pharmaceuticals. (simbolo azionario: 603087) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.92%
Rendimento medio negli ultimi 5 anni: 0.92%
Storico del rendimento da dividendi per Gan & Lee Pharmaceuticals. (603087) da 2013 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2025 | 1.48% | -8.07% |
| 2024 | 1.61% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 0.92% | 61.40% |
| 2021 | 0.57% | 111.11% |
| 2020 | 0.27% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 0.01% | 0.00% |
| 2016 | 0.01% | 0.00% |
| 2015 | 0.01% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | 0.09% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
US
|
|
| 2.70% |
FR
|
|
| 0.00% |
JP
|
|
| 2.10% |
US
|
|
| 0.00% |
CH
|
